Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Rifamycin sodium CR by Cosmo Pharmaceuticals for Bacterial Infections: Likelihood of Approval
Rifamycin sodium CR is under clinical development by Cosmo Pharmaceuticals and currently in Phase II for Bacterial Infections. According to...
Rifamycin sodium CR by Cosmo Pharmaceuticals for Hepatic Encephalopathy: Likelihood of Approval
Rifamycin sodium CR is under clinical development by Cosmo Pharmaceuticals and currently in Phase II for Hepatic Encephalopathy. According to...
Rifamycin sodium CR by Cosmo Pharmaceuticals for Hepatic Encephalopathy: Likelihood of Approval
Rifamycin sodium CR is under clinical development by Cosmo Pharmaceuticals and currently in Phase II for Hepatic Encephalopathy. According to...